106,420 Xylem Inc. $XYL Shares Sold by Candriam S.C.A.

Candriam S.C.A. reduced its stake in Xylem Inc. (NYSE:XYL) by 10.8% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 875,838 shares of the industrial products company’s stock after selling 106,420 shares during the quarter. Candriam S.C.A. owned approximately 0.38% of Xylem worth $89,020,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. State Street Corp lifted its position in shares of Xylem by 2.4% during the 2nd quarter. State Street Corp now owns 11,444,669 shares of the industrial products company’s stock worth $1,352,874,000 after purchasing an additional 270,972 shares during the last quarter. Perpetual Ltd boosted its stake in Xylem by 10.2% during the 3rd quarter. Perpetual Ltd now owns 129,946 shares of the industrial products company’s stock valued at $13,160,000 after purchasing an additional 11,993 shares during the period. TD Waterhouse Canada Inc. boosted its stake in Xylem by 1,922.6% during the 2nd quarter. TD Waterhouse Canada Inc. now owns 46,034 shares of the industrial products company’s stock valued at $5,400,000 after purchasing an additional 43,758 shares during the period. XXEC Inc. bought a new stake in Xylem during the 2nd quarter valued at approximately $850,841,000. Finally, NFJ Investment Group LLC acquired a new stake in Xylem in the 2nd quarter valued at approximately $4,116,000. Institutional investors own 87.96% of the company’s stock.

Insider Activity

In other news, Director D Koch bought 11,000 shares of the business’s stock in a transaction that occurred on Thursday, October 29th. The stock was acquired at an average cost of $89.60 per share, for a total transaction of $985,600.00. Following the completion of the purchase, the director owned 12,247 shares of the company’s stock, valued at $1,097,331.20. This trade represents a 882.12% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.32% of the company’s stock.

Xylem Stock Down 2.2%

XYL stock opened at $97.88 on Friday. Xylem Inc. has a twelve month low of $87.40 and a twelve month high of $152.15. The company has a quick ratio of 1.02, a current ratio of 1.39 and a debt-to-equity ratio of 0.23. The company has a market cap of $22.45 billion, a PE ratio of 21.65, a price-to-earnings-growth ratio of 1.63 and a beta of 1.01. The business’s 50-day simple moving average is $103.56 and its 200 day simple moving average is $116.48.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, October 27th. The industrial products company reported $1.44 EPS for the quarter, missing the consensus estimate of $1.45 by ($0.01). Xylem had a net margin of 11.94% and a return on equity of 12.06%. The firm had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.28 billion. During the same period last year, the company earned $1.37 EPS. The company’s revenue was down 3.0% on a year-over-year basis. On average, research analysts anticipate that Xylem Inc. will post 5.45 earnings per share for the current year.

Xylem Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th were given a dividend of $0.43 per share. The ex-dividend date was Thursday, August 27th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.8%. Xylem’s payout ratio is currently 38.05%.

Wall Street Analysts Forecast Growth

XYL has been the subject of a number of research analyst reports. Stifel Nicolaus cut their price target on Xylem from $141.00 to $114.00 and set a “buy” rating for the company in a report on Wednesday, October 28th. Mizuho set a $99.00 price objective on shares of Xylem in a research note on Wednesday, October 28th. Wolfe Research assumed coverage on shares of Xylem in a research report on Tuesday, September 15th. They set a “peer perform” rating on the stock. Robert W. Baird set a $123.00 target price on shares of Xylem in a research note on Wednesday, October 28th. Finally, JPMorgan Chase & Co. downgraded shares of Xylem from an “overweight” rating to a “neutral” rating and reduced their price target for the company from $118.00 to $90.00 in a report on Wednesday, October 28th. Nine analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $121.31.

About Xylem

Xylem Inc is a water technology company that develops equipment, software and services for managing water and wastewater. Its offerings include pumps and treatment systems, water-quality testing and analysis, smart meters, monitoring and control technologies, and services for detecting leaks and maintaining water infrastructure.

The company serves water and wastewater utilities, industrial and commercial customers, and residential markets. Its technologies support the movement, treatment, testing and efficient use of water across municipal and industrial systems.

Xylem was established in 2011 when it became an independent company following its spin-off from ITT Corporation.